Abstract
Chronic pain (CP) is a debilitating condition that impacts an individual’s physical and mental health. CP is common, affecting around 12-40% of individuals across the world. In this study, we conducted a genome-wide association study (GWAS) of lifetime incidence of CP in the All of Us Research Program, across six different ancestries in the United States (total Ncase = 137 043, total Ncontrol = 154 038). We found one genome-wide significant locus in the cross-ancestry meta-analysis on chromosome 5 (lead SNP: rs1196962975, p = 4.53E-08). Additionally, one locus on chromosome 11 (lead SNP: rs5795684) reached genome-wide significance in the admixed genetic ancestry sample (p = 1.13E-08). Cross-ancestry genetic correlations ranged from 0.40 – 0.78. CP was genetically correlated with a range of psychiatric, physical health, and immune traits, including anxiety (rg = 0.69, p = 1.82E-69), generalized addiction risk (rg = 0.39, p = 1.98E-18), and increased serum C-reactive protein levels (rg = 0.35, p = 5.28E-22). This study represents the largest cross-ancestral investigation of the genetics of lifetime incidence of chronic pain to date and demonstrates shared genetic effects between chronic pain and psychiatric disorders and other physical health conditions.
Highlights
48.8% of individuals were recorded as having a lifetime incidence of chronic pain.
One locus, rs5795684, was significant in individuals of admixed ancestry.
One additional locus, rs1196962975, was significant in a cross-ancestral meta-analysis.
Genetic associations were enriched in brain areas such as the nucleus accumbens and amygdala.
Chronic pain was moderately to highly genetically correlated to other physical and psychiatric health traits.
Competing Interest Statement
PNRV, JVB, NS, ASH, AA, and ECJ report no conflicts of interest. SH discloses personal fees from Vertex.
Funding Statement
This work was supported by the National Institute for Drug Abuse [grant numbers R03DA059747, K01DA051759, T32DA007261, and R01DA054869]; the National Institute of Nursing Research [grant number R90NR021799]; the National Institute on Alcohol Abuse and Alcoholism [grant number K01AA030083]; and the National Institute on Neurological Disorders and Stroke [grant number RM1NS135283].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The All of Us Research Program data are available to registered and approved All of Us researchers. Genetic data requires controlled tier access; researchers can register for access through their institutions. Summary statistics resulting from this study will be deposited to the GWAS Catalog upon publication. Code for this project will be available upon publication on the All of Us workbench as a public workspace and on GitHub.
